<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We studied clinical effect of a combination therapy with cefozopran (CZOP) and <z:chebi fb="0" ids="28864">tobramycin</z:chebi> (TOB) for <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> in 80 patients with <z:e sem="disease" ids="C0018939" disease_type="Disease or Syndrome" abbrv="">hematologic diseases</z:e> in 15 institutes </plain></SENT>
<SENT sid="1" pm="."><plain>Combined doses with CZOP 2 g and TOB 60-90 mg twice a day had been given intravenously </plain></SENT>
<SENT sid="2" pm="."><plain>Of the 80 patients, 61 patients (42 with <z:hpo ids='HP_0002488'>acute leukemia</z:hpo>, 10 with malignant <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, 3 with <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, 2 with <z:hpo ids='HP_0011010'>chronic</z:hpo> myeloid <z:hpo ids='HP_0001909'>leukemia</z:hpo>, 2 with <z:hpo ids='HP_0006775'>multiple myeloma</z:hpo>, and 2 with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo>) were evaluable </plain></SENT>
<SENT sid="3" pm="."><plain>Those consisted of 6 patients with <z:mpath ids='MPATH_681'>septicemia</z:mpath>, 49 with suspected <z:mpath ids='MPATH_681'>septicemia</z:mpath>, 3 with <z:hpo ids='HP_0002090'>pneumonia</z:hpo>, and 3 with other <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Clinical efficacy by the treatment was excellent in 24, good in 17, fair in 9, and poor in 11 patients, and the overall efficacy rate including excellent and good was 67.2% </plain></SENT>
<SENT sid="5" pm="."><plain>Microbiologically, 5 of the 6 patients with <z:mpath ids='MPATH_681'>septicemia</z:mpath> (1 coagulase negative Staphylococcus, 2 S. pneumoniae, 1 S. oralis, and 1 E. coli) were responded </plain></SENT>
<SENT sid="6" pm="."><plain>The efficacy rate in patients with severe <z:hpo ids='HP_0001913'>granulocytopenia</z:hpo> showing 100/microliter or lesser neutrophil counts during the drug administration was 57.1% (12/21) </plain></SENT>
<SENT sid="7" pm="."><plain>Side effects and abnormal changes of clinical laboratory findings were observed in 5 patients, and 16 patients, respectively, but most of them were mild </plain></SENT>
<SENT sid="8" pm="."><plain>The findings above suggested that the combination therapy with CZOP and TOB is useful as an empiric therapy for severe <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> in patients with <z:e sem="disease" ids="C0018939" disease_type="Disease or Syndrome" abbrv="">hematologic diseases</z:e> </plain></SENT>
</text></document>